2017
DOI: 10.24170/4-3-2086
|View full text |Cite
|
Sign up to set email alerts
|

Peritoneal dialysis in congestive heart failure

Abstract: Even in renal failure patients on PD, introduction of icodextrin has been shown to decrease extra cellular water and improve hemodynamics. Icodextrin offers several advantages:■ It offers more physiologic ultrafi ltration.■ Euvolemia can be maintained without additional dextrose exchanges.■ Single exchange is easy on lifestyle and decreases risk of touch contamination and hence incidence of peritonitis. Neither of the patients required hospitalization for either cardiac or dialysis related issues, as compared … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 19 publications
0
3
0
1
Order By: Relevance
“…[ 10 11 ] Whatever the cause, all heart failure patients eventually progress to a refractory stage characterized by worsening renal function and resistance to diuretic therapy with attending severe edema. [ 12 ] We studied the effect of peritoneal ultrafiltration in these patients with chronic refractory congestive cardiac failure.…”
Section: Discussionmentioning
confidence: 99%
“…[ 10 11 ] Whatever the cause, all heart failure patients eventually progress to a refractory stage characterized by worsening renal function and resistance to diuretic therapy with attending severe edema. [ 12 ] We studied the effect of peritoneal ultrafiltration in these patients with chronic refractory congestive cardiac failure.…”
Section: Discussionmentioning
confidence: 99%
“…Fluid balance may possibly act as a biomarker of severity in critical illness [22]. A neutral fluid balance has also been shown to improve outcomes in acute lung injury.…”
Section: Other Aspects Of Adequacymentioning
confidence: 99%
“…Peritoneal dialysis (PD) is useful for patients with end-stage renal disease with hemodynamic instability because of the continuous and slow ultrafiltration. 1,2 Furthermore, PD is an attractive therapeutic option in situations where hemodialysis (HD) may be undesirable due to a sudden onset of intradialytic hypotension and reductions in cerebral blood flow. 3 However, a meta-analysis on the risks of stroke in end-stage renal disease patients on PD compared to HD showed no differences in the risks of all types of stroke or ischemic stroke between PD and HD.…”
Section: Introductionmentioning
confidence: 99%